Dr. John Campbell

Select Subcommittee on the Coronavirus Pandemic Chairman Dr. Brad Wenstrup (Ohio) https://www.youtube.com/watch?v=O_eXm9wOkS8 https://www.youtube.com/watch?v=10I3hQUf3oI&t=10s https://oversight.house.gov/subcommittee/select-subcommittee-on-the-coronavirus-pandemic/ https://www.youtube.com/watch?v=9fKWYFsupQk https://oversight.house.gov/release/wenstrup-opens-investigation-into-federal-covid-19-vaccine-mandates/ https://oversight.house.gov/release/wenstrup-to-hold-first-hearing-on-covid-origins/ Investigation into overreaching, federal COVID-19 vaccination mandates and policies at the, Department of Defense (DOD), U.S. Office of Personnel Management (OPM), Department of Labor (DOL), and Department of Health and Human Services (HHS). Chairman Wenstrup is requesting access to all documents, communications, and guidance, utilized by these agencies to craft their coercive policies prior to forcing a novel vaccine — that did not stop the spread or transmission of the virus — on millions of Americans. At the Select Subcommittee’s hearing on vaccine mandates last week, expert witnesses highlighted the Biden Administration’s abuse of executive power and disregard for individual freedoms that resulted in employment termination, decreased military readiness, and increased distrust in public health authorities. The Select Subcommittee is seeking further information from DOD, OPM, DOL, and HHS regarding any political interference by the Biden White House and other outside organizations on federal COVID-19 vaccine mandates.

Select Subcommittee on the Coronavirus Pandemic Chairman Dr. Brad Wenstrup (Ohio) https://www.youtube.com/watch?v=O_eXm9wOkS8 https://www.youtube.com/watch?v=10I3hQUf3oI&t=10s https://oversight.house.gov/subcommittee/select-subcommittee-on-the-coronavirus-pandemic/ https://www.youtube.com/watch?v=9fKWYFsupQk https://oversight.house.gov/release/wenstrup-opens-investigation-into-federal-covid-19-vaccine-mandates/ https://oversight.house.gov/release/wenstrup-to-hold-first-hearing-on-covid-origins/ Investigation into overreaching, federal COVID-19 vaccination mandates and policies at the, Department of Defense (DOD), U.S. Office of Personnel Management (OPM), Department of Labor (DOL), and Department of Health and Human Services (HHS). Chairman Wenstrup is requesting access to all documents, communications, and guidance, utilized by these agencies to craft their coercive policies prior to forcing a novel vaccine — that did not stop the spread or transmission of the virus — on millions of Americans. At the Select Subcommittee’s hearing on vaccine mandates last week, expert witnesses highlighted the Biden Administration’s abuse of executive power and disregard for individual freedoms that resulted in employment termination, decreased military readiness, and increased distrust in public health authorities. The Select Subcommittee is seeking further information from DOD, OPM, DOL, and HHS regarding any political interference by the Biden White House and other outside organizations on federal COVID-19 vaccine mandates.

Great to learn from professor Robert Clancy. Every time I learn so much. Robert is a consultant physician and pioneering immunologist, professor of medicine, emeritus professor of pathology, doctor of medicine, doctor of philosophy and doctor of science, author, teacher and broadcaster. Also holder of the Order of Australia.

Journals have devolved into information laundering operations for the pharmaceutical industry Pharmaceutical company advertising in The Lancet https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61019-2/fulltext (Illustration: Margaret Shear, Public Library of Science) https://journals.plos.org/plosmedicine/article/figure?id=10.1371/journal.pmed.0020138.g001 Editor, The Lancet, Richard Horton “Journals have devolved into information laundering operations for the pharmaceutical industry.” (Published in ‘The dawn of McScience’) Former New England Journal of Medicine Editor, Marcia Angell Describing information from the pharmaceutical industry as coming, “mixed with hyperbole, bias and misinformation, and there is often no way to tell which is which.” (Published in ‘The truth about the drug companies: how they deceive us and what to do about it.’) Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020138 Journals, “primarily a marketing machine” and co-opting “every institution that might stand in its way” Some studies found that journal advertisements were more strongly associated with prescribing than the scientific articles in the same journals, others found advertising associated with less rational prescribing, and greater prescribing costs. However, none found associations between exposure to journal advertisements and improved quality of prescribing, reduced cost, or reduced prescribing overall. “the findings support the case for reforms to reduce negative influence to prescribing from pharmaceutical promotion.” Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review https://pubmed.ncbi.nlm.nih.gov/20976098/ (PLoS Medicine) Background: Pharmaceutical industry claims that promotion provides scientific and educational information to physicians. To examine the relationship between exposure to information from pharmaceutical companies to prescribing. Outcome measures: Quality, quantity, and cost. Exposures included Pharmaceutical sales representative visits Journal advertisements Attendance at pharmaceutical sponsored meetings Mailed information Prescribing software Participation in sponsored clinical trials Wide literature search, 58 included studies with 87 analyses. Five found associations between exposure to pharmaceutical company information and lower quality prescribing Five included studies found evidence for association with higher costs 38 studies, associations between exposure and higher frequency of prescribing Conclusions Studies of exposure to information provided directly by pharmaceutical companies have found associations with higher prescribing frequency, higher costs, or lower prescribing quality We did not find evidence of net improvements in prescribing We recommend that practitioners follow the precautionary principle, and thus avoid exposure to information from pharmaceutical companies. John Paul II https://www.gmwatch.org/en/news/archive/2004/7941-the-dawn-of-mcscience "overriding financial interests" operate in biomedical and pharmaceutical research. These forces prompted, "decisions and products which are contrary to truly human values and to the demands of justice." "the pre-eminence of the profit motive in conducting scientific research ultimately means that science is deprived of its epistemological character, according to which its primary goal is discovery of the truth. The risk is that when research takes a utilitarian turn, its speculative dimension, which is the inner dynamic of man's intellectual journey, will be diminished or stifled."

WHO admits excess deaths Global excess deaths associated with COVID-19, January 2020 - December 2021 https://www.who.int/data/stories/global-excess-deaths-associated-with-covid-19-january-2020-december-2021 New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL A comprehensive view of global deaths directly and indirectly associated the COVID-19 pandemic. The World Health Organization (WHO) is tracking global excess mortality as the pandemic evolves over time to reveal a picture of its full impact and burden on countries, health systems and individuals. 'Excess mortality' is defined as the difference between the total number of deaths that have occurred and the number of deaths that would have been expected in the absence of the pandemic i.e. a no-COVID-19 scenario. Understanding the excess mortality: Excess mortality includes deaths attributable directly to COVID-19, includes deaths attributable directly to COVID-19 that were not counted or reported, includes deaths indirectly associated with COVID-19, due to other causes and diseases, resulting from the wider impact of the pandemic on health systems and society. It is minus any deaths that would have occurred under normal circumstances but were averted due to pandemic-related changes in social conditions and personal behaviors, e.g. less traffic deaths or influenza deaths due to local lockdowns and less travel. No mention of Adverse effects of lockdowns, social, economic, psychological, psychiatric Adverse events of medical interventions (iatrogenesis) https://www.cbc.ca/news/canada/hamilton/covid-mcmaster-fall-booster-shots-1.6923295 https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-guidance-use-covid-19-vaccines-fall-2023.html Vaccination of individuals who are pregnant Studies continue to support vaccination during pregnancy. Safety of Omicron-containing bivalent mRNA COVID-19 vaccines The safety profile of the bivalent mRNA COVID-19 vaccine boosters is comparable to that of original mRNA COVID-19 vaccine boosters No evidence on VE against infant outcomes is available for vaccination with bivalent mRNA vaccines in persons who are pregnant. In Western Australia https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Total AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. 26.41 per 10 thousand 2.641 per thousand 0.241% One in 414 doses Of these AEFI, (adverse events following immunisation) 10,428 (97%) occurred after a COVID-19 vaccine 21 times more common than ‘conventional’ vaccines Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 One in 35 recipients (2.8%) had vaccine-associated myocardial injury

The truth about myocarditis and Covid vaccines: After ….. https://www.dailymail.co.uk/health/article-12339279/Covid-vaccine-myocarditis-heart-Elon-Musk-bronny-james.html Two facts — both of which are widely misinterpreted Fact One mRNA jabs can cause myocarditis, an extremely rare complication that causes inflammation of the heart muscle) Fact two That heart-related deaths are massively above levels seen pre-pandemic. Conflating the two is not only incorrect, but irresponsible. Swiss study Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%). One in 35 recipients (2.8%) had vaccine-associated myocardial injury Matched controls, elevated high-sensitivity cardiac troponin T concentration Significantly higher in post vaccination group p<0.001 N = 777 per group Thai study Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414075/ After BNT162b2, 2nd dose, Thai adolescents, aged 13–18 years, n = 314 Most common cardiovascular signs and symptoms Tachycardia (7.64%) Shortness of breath (6.64%) Palpitation (4.32%) Chest pain (4.32%) Hypertension (3.99%) One participant could have more than one sign and/or symptom Cardiovascular manifestations were found in 29.24% of patients Seven participants (2.33%) exhibited at least one elevated cardiac biomarker Myopericarditis was confirmed in one patient after vaccination. Two patients had suspected pericarditis Four patients had suspected subclinical myocarditis The clinical presentation of myopericarditis after vaccination was usually mild and temporary, with all cases fully recovering within 14 days. Hence, adolescents receiving mRNA vaccines should be monitored for cardiovascular side effects. Israeli study A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://pubmed.ncbi.nlm.nih.gov/36097844/ Incidence of myocardial injury after fourth dose BNT162b2 mRNA vaccine (Pfizer-BioNTech) N = 324 High-sensitivity cardiac troponin (hs-cTn) Vaccine-related myocardial injury was defined as hs-cTn elevation above the 99th percentile upper reference limit, and >50% increase from baseline measurement. Reported vaccine-related adverse reactions Fatigue in 39 (12.04%) Myalgia in 32 (9.88%) Sore throat in 21 (6.48%) Headache in 18 (5.5%) Fever ≥38°C in 16 (4.94%) Chest pain in 12 (3.7%) Palpitations in 7 (2.16%) Shortness of breath in one (0.3%) Vaccine-related myocardial injury in two (0.62%) The two cases had mild or no symptoms and no clinical sequela. US study Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis https://www.preprints.org/manuscript/202307.1198/v1 All autopsy studies, vaccine-induced myocarditis as a possible cause of death Most cases had symptoms consistent with myocarditis prior to death We established that all 28 deaths were causally linked to COVID-19 vaccination by independent adjudication. Number of days from last COVID-19 vaccination until death UK government data on excess deaths https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9 Age groups and causes of death

Facebook Bowed to White House Pressure, Removed Covid Posts Internal Meta emails say pressure from Washington was behind a decision to take down posts attributing pandemic to man-made virus https://www.wsj.com/articles/facebook-bowed-to-white-house-pressure-removed-covid-posts-2df436b7 https://www.telegraph.co.uk/world-news/2023/07/28/facebook-deleted-covid-virus-manmade-posts-pressure-biden/ Email from Nick Clegg Asked why company was removing rather than labelling or demoting post about viral origins Facebook vice-president in charge of content policy “We were under pressure from the administration and others to do more,” “We shouldn’t have done it.” Jim Jordan, Republican house judiciary committee “documents begin to reveal the pressure that Facebook and other social media companies were under to alter their content moderation policies, and remove protected speech to appease the federal government, particularly the Biden White House”. First Amendment https://constitution.congress.gov/constitution/ Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the people peaceably to assemble, and to petition the Government for a redress of grievances. New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL

New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL Royal colleges in the UK Have received more than £9m in marketing payments from drug and medical devices companies since 2015 The Royal College of Physicians and the Royal College of General Practitioners, biggest recipients of industry money https://www.bmj.com/content/bmj/382/bmj.p1658.full.pdf BMJ 2023;382:p1658 http://dx.doi.org/10.1136/bmj.p1658 Published: 26 July 2023 Medical royal colleges do not always disclose publicly the millions of pounds they receive from drug and medical device companies. The BMJ asked the colleges to disclose all payments from industry …. but they all refused to do so. The colleges are not obliged to disclose these payments; they are not included in their annual reports, and are only available through voluntary industry transparency initiatives, which experts say have severe limitations. Drug companies Gave £7.5m to royal colleges in the years 2015 to 2022, (for which data were available) Royal College of Physicians, £ 2.8 million Royal College of GPs, £2.4 million The biggest donor overall was Pfizer £1.8m of payments Novo Nordisk with £730 000 Daiichi Sankyo with £478 000 Since 2012 the College of Psychiatrists of Ireland Has refused to take any sponsorship from drug companies, noting, research “overwhelmingly” shows that clinicians are influenced by industry marketing, and that this affects prescribing. Emma Hardy, All Party Parliamentary Group on Surgical Mesh Implants. “Medicine is literally a matter of life and death, and patients must be confident they are receiving the best treatment available for the right reasons.” https://www.bbc.co.uk/news/health-45604199 Up to 170,000 people who have had hernia mesh implants in England in the past six years could face complications, Margaret McCartney, GP, former Royal College of General Practitioners trustee and council member “Even if we are told the information is independent, funding skews the types of education or information that gets made,” “It means that we become less independent, because we are not setting our own priorities, and that’s bad for the profession.” Conflict of interest scandals In March 2023 the Association of the British Pharmaceutical Industry temporarily suspended the drug company Novo Nordisk, because of “serious breaches” of the association’s code of practice. (The ABPI only saves the data on payments for the most recent three years and deletes historical data) Data compiled from Disclosure UK An online database run by the Association of the British Pharmaceutical Industry (ABPI), (where drug companies disclose payments to healthcare organisations, patient groups, and health professionals, who have consented for these payments to be made public) Piotr Ozieranski, (Bath University), and Shai Mulinari, (Lund University) Payments were reported under wide categories, were changed without explanation, or were inconsistent between data sources. It is impossible to tell how much money goes to each recipient, “without many hours of forensic work,”

Myocardial Injury after COVID-19 mRNA-1273 Booster Vaccination https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2978 Department of Cardiology and Cardiovascular Research Institute Basel (ESC Heart Failure, open-access journal of the Heart Failure Association of the European Society of Cardiology) Prospective active surveillance study (Not a retrospective passive surveillance study) Industry independent, instigated by the investigators Aims Incidence and potential mechanisms of oligosymptomatic myocardial injury, following COVID-19 mRNA booster vaccination. Safety net for those already boosted, screening and prevention of complications Methods and Results December 2021 to February 2022 Hospital employees scheduled to undergo mRNA-1273 booster vaccination, assessed for mRNA-1273 vaccination-associated myocardial injury, defined as acute dynamic increase in high-sensitivity cardiac troponin T (hs-cTnT) concentration, above the sex-specific upper-limit of normal on day 3 (48-96h) after vaccination without evidence of an alternative cause. 777 participants Median age 37 years, 69.5% women 40 participants (5.1%) had elevated high-sensitivity cardiac troponin T concentration on day 3 (Taken as above the 99th percentile for age and sex) mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%). One in 35 recipients (2.8%) had vaccine-associated myocardial injury Of the 777, 2 women had chest pain Of these 22 cases with mRNA-1273 vaccine-associated myocardial injury Twenty cases occurred in women Two in men Hs-cTnT-elevations were mild and only temporary. No patient had ECG- changes, none developed major adverse cardiac events within 30 days In the overall booster cohort hs-cTnT concentrations, on day 3 Median 5 ng/L, IQR, 4-6 Matched controls (n=777), 3 ng/L IQR, 3-5 Significantly higher p less than 0.001 (If elevated on day3, given warning, investigations and advice) No MACE (major adverse cardiac events) within 30 days Cases had comparable systemic reactogenicity Concentrations of cytokines and cytokine antagonists were markers quantifying systemic inflammation Lower concentrations GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) induces the development of monocytes, neutrophils, eosinophils, and myeloid and dermal dendritic cells. IFN- λ1(IL-29) a group of anti-viral cytokines, that consists of four IFN-λ molecules Conclusion mRNA-1273 vaccine-associated myocardial injury was more common than previously thought, being mild and transient, and more frequent in women versus men. The possible protective role of IFN-λ1(IL-29) and GM-CSF warrant further studies. Similar Pfizer studies A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://pubmed.ncbi.nlm.nih.gov/36097844/ A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2687\ NZ Pfizer add https://www.everydayheroestakeaction.co.nz/?cmp=4cb06943-ef5f-42d8-a5ec-558705280295&ttype=IN&fbclid=PAAabAcBB-HdSUGJ0ZWreXCquT1cuen2z6RbI5ja2lhiMYCDlfyTVFYqj-Ri0_aem_ASwusg7kvCVjmKH2P0IcpOhiofhq24SJ5j9olm-Nu18iz66ygOkrGjbnIu8km0HD9fA2UY50a5Fiu1h4xVVS7fbW

Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/vitamin-d-deficiency-and-insufficiency-among-us-adults-prevalence-predictors-and-clinical-implications/44E436843510FE6BDE856D5BCB9C651F (University of Michigan School of Medicine, 2018) Vitamin D deficiency (VDD) and insufficiency (VDI) are increasing at a global level Serum 25-hydroxyvitamin D (25(OH)D) measurements were collected from 26,010 adults (National Health and Nutrition Examination Survey, NHANES) VDD, less than 50 nmol/l (20 ng ml) VDI, 50 to 75 nmol/l (20 – 25 ng ml) Prevalence VDD, 28·9% VDI, 41·4 % Adults who were black, less educated, poor, obese, physically inactive and infrequent milk consumers Obese adults, 3·09 times higher prevalence of VDD (1·80 times higher prevalence of VDI) Physically inactive adults, 2·00 times VDD (1·36 times higher prevalence of VDI) Vitamin D status in the United States, 2011–2014 https://academic.oup.com/ajcn/article/110/1/150/5487983?login=false Persons with higher vitamin D dietary intake or who used supplements had lower prevalences of at risk of deficiency or inadequacy. Vitamin D deficiency 2.0: an update on the current status worldwide https://www.nature.com/articles/s41430-020-0558-y Most studies did not meet the basic requirements of a nutrient intervention study ~40% of Europeans are vitamin D deficient, and 13% are severely deficient Vitamin D deficiency (serum 25-hydroxyvitamin D less than 50 nmol/L or 20 ng/ml), associated with unfavourable skeletal outcomes, including fractures and bone loss Level of more than 50 nmol/L or 20 ng/ml is, therefore, the primary treatment goal Severe vitamin D deficiency, below less than 30 nmol/L (or 12 ng/ml), dramatically increases the risk of excess mortality, infections, and many other diseases, and should be avoided whenever possible. Given its rare side effects and its relatively wide safety margin, it may be an important, inexpensive, and safe adjuvant therapy for many diseases, but future large and well-designed studies should evaluate this further. Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12404 Vitamin D exposure was associated with 40% lower dementia incidence versus no exposure. (Prospective, n = 12,388) Low vitamin D serum levels as risk factor of Alzheimer’s disease: a systematic review and meta-analysis https://ejnpn.springeropen.com/articles/10.1186/s41983-023-00676-w Serum vitamin D levels, related to cognitive dysfunctions, e.g. dementia, including Alzheimer’s disease Past studies vary in results on whether vitamin D levels correlated with the development of AD. Meta-analysis, up to December 2022 AD, 75% of dementias Results 6 studies, n = 10,884 Vitamin D receptors throughout the brain Patients, vitamin D serum levels (less than 25 ng/ml), had an increased risk of developing AD, compared to more than 25 ng/ml HR: 1.59 Severe deficiency (less than 10 ng/ml) having the strongest association, compared to moderate vitamin D deficiency (10–20 ng/ml). Vitamin D may promote the clearing of amyloid plaques Vitamin D also prevents cognitive dysfunction via neuroprotection, neurotrophy, neurotransmission, and neuroplasticity Potential to prevent neuroinflammation, inhibits proinflammatory cytokines https://www.gov.uk/government/publications/vitamin-d-for-vulnerable-groups/vitamin-d-and-clinically-extremely-vulnerable-cev-guidance In the UK during autumn and winter, everyone is advised to take a supplement containing, 10 micrograms (400 international units) of vitamin D a day https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/

Similar pattern of excess deaths in many countries around the world ONS, UK, week ending 7 July 2023 (Week 27), https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/7july2023 Deaths registered in the UK, 11,147, (2.9% above) https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

Yes, and how many times can a man turn his head And pretend that he just doesn’t see (Bob Dylan) Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis https://www.preprints.org/manuscript/202307.1198/v1 COVID-19 vaccines have been linked to myocarditis which in some circumstances can be fatal. This systematic review aims to investigate potential causal links between COVID-19 vaccines and death from myocarditis using post-mortem analysis. A systematic review of all published autopsy reports involving COVID-19 vaccination-related myocarditis Through July 3rd, 2023. All autopsy studies that include COVID-19 vaccine-induced myocarditis as a possible cause of death were included Causality in each case Determined by three independent reviewers with cardiac pathology experience and expertise. Results Initially identified 1,691 studies After screening, 14 papers, 28 autopsy cases. (The cardiovascular system was the only organ system affected in 26 cases) In 2 cases, myocarditis a consequence from multisystem inflammatory syndrome (MIS). Number of days from last COVID-19 vaccination until death We established that all 28 deaths were causally linked to COVID-19 vaccination by independent adjudication. Conclusions Temporal relationship, internal and external consistency Deceased, with known COVID-19 vaccine-induced myocarditis Pathobiological mechanisms Related excess death Complemented with autopsy confirmation Independent adjudication Application of the Bradford Hill criteria Overall epidemiology of vaccine myocarditis suggests there is a high likelihood of a causal link between COVID-19 vaccines and death from suspected myocarditis, in cases where sudden, unexpected death has occurred in a vaccinated person. Urgent investigation is required for the purpose of risk stratification, and mitigation, in order to reduce the population occurrence of fatal COVID-19 vaccine-induced myocarditis. More information Most cases had symptoms consistent with myocarditis prior to death, (chest pain, effort intolerance) Choi et al, a 22-year-old Korean man Autopsy showed intense inflammation and destruction of cardiac tissue including the conduction system. Other cases had no reported symptoms before death. Gill et al reported two boys, age 16 and 17, who died a few days after mRNA injection while asleep at home. Autopsies revealed patchy inflammation suggesting that sudden arrhythmic death had occurred.

New hope children centre https://www.newhopeuplands.org If you would like to support the work in Africa, donations are welcome using the PayPal link below. 100% of funds go directly to Africa. Thank you. https://www.paypal.com/donate/?hosted_button_id=XS59XPZ527YFL It is generally acknowledged that adverse events are under-reported around the world, https://www.tga.gov.au/news/media-releases/new-web-service-helps-consumer-reporting-side-effects?fbclid=IwAR3CWUsyEoZ54fzXE1TIEqhUAZjynzMeEjRf2w_8W-jASWmLnwj1_7odSFM with estimates that 90-95% of adverse events are not reported to regulators. In recent years evidence has emerged that adverse event reports from consumers contain information that is useful for monitoring the safety of therapeutic products, but there is low awareness of available reporting systems. In Western Australia https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Total AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. 26.41 per 10 thousand 2.641 per thousand 0.241% How to report in Australia https://aems.tga.gov.au https://aems.tga.gov.au/privacy/ https://aems.tga.gov.au/report-unregistered/?id=2da2d6a9-0d26-ee11-8172-005056a9ce6f How to report in UK https://yellowcard.mhra.gov.uk How to report in the US https://vaers.hhs.gov/reportevent.html https://vaers.hhs.gov/esub/index.jsp Yellow Card: Yellow card scheme, Don’t wait for someone else to report it https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported. Under-Reporting of Adverse Drug Reactions https://link.springer.com/article/10.2165/00002018-200629050-00003 12 countries, 43 numerical estimates of under-reporting. The median under-reporting rate across the 37 studies was 94% In primary care Non serious, 95% under reported Serious or severe, 80% under reported Hospital based More severe or serious, 85% to 95% under reported As an Australian I feel utterly let down. Grateful for WA for making this report available, but it leaves such a bad taste in the mouth to know how we were lied to. I did not want the vaccine and felt pushed from all sides to get it. As a West Australian I can say that doctors were discouraged to report adverse events and were reprimanded if they reported too many. The red flag system in Australia took about 45mins to report and doctors were not paid to do so. This data is absolutely doctored and controlled. I fled WA to another State with my family as soon as the unvaccinated could travel outside of the State domestically. I work in the medical field and lived in a suburb surrounded by the medical profession. The GPs who weren't afraid to report these events started getting phone calls from the Department of Health questioning their opinions and asking them to retract their reports and registrars/junior doctors working in hospitals were told to remove vaccine injury from patient notes by senior staff. My mother was vaccine injured and did not report it to the VAERS system. I imagine others like her are part of why the US has poor data on vaccine side effects. I live in Alberta, Canada. I worked for a group of general practitioners during the height of covid and the vaccine implementation. I can tell you first hand that the physicians I worked for purposefully did NOT report vaccine side effects regardless of their legal obligation to due so. When I inquired about it, it was strongly implied that I mind my own business. Interesting. I am in BC and know my reported side affects were not reported as asked later and was told could not tell me and did not know who to direct me to.

Senator Gerard Rennick (Queensland) in an open discussion about excess deaths and vaccine related issues in Australia. Western Australian Vaccine Safety Surveillance – Annual Report 2021 https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Western Australia had implemented a stringent lockdown of borders and there were virtually NO cases of Covid-19 in Western Australia during 2021. The vaccine role out began February 2021. So that demonstrates the adverse reactions resulted directly from the Covid-19 vaccines and NOT the Covid-19 virus. Is there something here for the rest of Australia and indeed the world to learn from? Of all the adverse events following immunisation that took place in the WA population, what percentage would you estimate were actually reported to the Western Australian Vaccine Safety Surveillance (WAVSS)? What do you think the culture was in the health care services during the vaccine role out, was it to encourage reporting of potential adverse events or was the culture to discourage reporting to WAVSS? In WA in 2020, 2,071,167 doses of pre-covid (traditional) vaccines were given to the population as a whole, this resulted in 270 reports of adverse events following immunisation. For the 3,948,673 COVID-19 vaccines given in 2021, there were 10,726 individual AEFI reports in 2021. (97% of these reports followed covid vaccination) What do you think this tells us about the frequency of adverse events following covid vaccines in comparison to traditional vaccines? This is a horrendous volume of adverse events following immunisation. Do you feel the rate of adverse events would be equally high throughout the rest of Australia? (or was WA a ‘special case’) Total reported AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. For non-covid (traditional) vaccinations in WA, during the same 2021-time frame there were 11.1 events per 100,000 doses. Why did we had to waite until July 2023 to get this data? Should this have been seen as a ‘red flag’ by the regulators contemporaneously in 2021? If so, what should they have done about the problem? Some of the important AEFI that have been specifically monitored by the TGA-coordinated national surveillance vaccine safety program include, Anaphylaxis, Thrombosis with thrombocytopaenia syndrome (TTS), Immune thrombocytopenic purpura (ITP), Guillain-Barré syndrome (GBS), Myocarditis, Pericarditis, Myopericarditis, Chest pain, Deep venous thrombosis, Pulmonary embolism and Bell’s palsy, to name but a few. Given that we know all of this now, how should this effect the regulatory approval of the current mRNA vaccines? In 2021 there were 1,125 appointments made at the adult vaccine safety clinic at Sir Charles Gairdner Hospital, up from seven appointments made in 2020. Do you consider this level of referrals indicated the vaccines were safe? In 2021 there were 439 appointments made at the Perth Children’s Hospital specialist immunisation clinic, up from 214 in 2020. Does this have any implications for vaccinating children with covid vaccines?

ONS excess deaths data https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/30june2023 Week ending 30 June 2023 (Week 26) 10,373 deaths were registered in England and Wales 129 of these deaths mentioned novel coronavirus (COVID-19), accounting for 1.2% of all deaths. Of the 129 deaths involving COVID-19 61.2% (79 deaths) had this recorded as the underlying cause of death Number of deaths was above the five-year average Private homes, 22.9% above, (589 excess deaths) Hospitals, 6.1% above, (257 excess deaths) Care homes, 3.7% above, (70 excess deaths) The number of deaths registered in the UK in the week 11,763 8.8% above the five-year average (950 excess deaths) European excess deaths https://ec.europa.eu/eurostat/cache/recovery-dashboard/ https://ec.europa.eu/eurostat/statistics-explained/index.php?oldid=509982#Excess_mortality_in_the_EU_between_January_2020_and_May_2023 Excess mortality in the EU between January 2020 and May 2023 Followed the covid waves in 2020 and 2021 Following based on 2016-2019 EU data, 2022 January, + 8.1% February, + 8.3% March, + 6.7% April, + 12% May, + 8% June, + 8.4% July, + 17.1% 58, 000 additional deaths in the EU in July 2022 (2.8 % in July 2020, 11 500 excess deaths) (5.7 % in July 2021, 19 700 excess deaths) Auguste, + 13.9% (7.6 % in August 2020, 27 300 excess deaths) (9.1 % in August 2021, 36 000 excess deaths) September, + 10.3 % October, + 11.6% November, + 8.7% December, + 20.0 % 92, 500 additional deaths in December 2022 in the EU January-March, 2023 January, + 3.9 % February, -1.4 % March, + 0.9 % April, + 3.3 % (11, 900 additional deaths) May, + 2.9 % (8, 100 additional deaths) January 2020 to May 2023 1, 765, 000 additional deaths (compared with the average number for the same period in 2016-2019) 2020, 11.8 % higher 2021, 14.0 % higher 2022, 11.1 % higher First five months of 2023, 1.9 % higher In 2022 Romania (3.4 %) Sweden (3.9 %) Hungary (5.2 %) Cyprus (26.4 %) Malta (17.9 %) Finland (17.1 %) In the first five months of 2023 Bulgaria (-9.3 %) Romania (-9.0 %) Lithuania (-8.5 %) Ireland (10.2 %) Netherlands (9.5 %) Austria (9.3 %) Vaccine safety: content alleging that vaccines cause chronic side effects, outside of rare side effects that are recognized by health authorities https://support.google.com/youtube/answer/11161123?sjid=13083388330982415003-EU https://support.google.com/youtube/answer/9891785?sjid=13083388330982415003-EU Claims about COVID-19 vaccinations that contradict expert consensus from local health authorities or WHO Claims that an approved COVID-19 vaccine will cause death, infertility, miscarriage, autism, or contraction of other infectious diseases Claims that COVID-19 vaccines will make people who receive them magnetic

Western Australian Vaccine Safety Surveillance – Annual Report 2021 https://www.health.wa.gov.au/~/media/Corp/Documents/Health-for/Immunisation/Western-Australia-Vaccine-Safety-Surveillance-Annual-Report-2021.pdf Report describes adverse events following immunisation (AEFI) Reported to Western Australian Vaccine Safety Surveillance (WAVSS) system For vaccinations received in 2021. The format of this Annual Report differs, to enable description of the impact of the program COVID-19 vaccination started in February 2021 In 2021, Western Australia 5,756,723 vaccine doses were administered, up from 2,071,167 in 2020. Of this amount, 3,948,673 were COVID-19 vaccines In 2021, a significant increase in reports of AEFI 10,726 individual AEFI reports in 2021, up from 270 in 2020. (200 reports from Influenza and routine vaccinations in 2021) Of these AEFI, (adverse events following immunisation) 10,428 (97%) occurred after a COVID-19 vaccine Similar volume of reports in the rest of Australia (as reported by the Therapeutic Goods Administration) https://www.tga.gov.au/resources/article?f[0]=type:189 In Western Australia Total AEFI rate following a COVID-19 vaccine was 264.1 per 100,000 doses. 26.41 per 10 thousand 2.641 per thousand 0.241% Non covid vaccinations, WA, 2021 11.1 events per 100,000 doses 0.0111% Comparison with US in 2021 Vaccine Adverse Event Reporting System https://vaers.hhs.gov/data/datasets.html 148.3 per 100,000 doses Vaxzevria (AstraZeneca) 306.1 per 100,000 doses Comirnaty (Pfizer) 244.8 per 100,000 doses (US, 122 per 100,000) Spikevax (Moderna) 281.4 per 100,000 doses (US, 187 per 100,000) Why the difference? This likely reflects differences in the sensitivity of passive adverse event reporting systems between the two jurisdictions. Some of the important AEFI that have been specifically monitored TGA-coordinated national surveillance vaccine safety program Anaphylaxis Thrombosis with thrombocytopaenia syndrome (TTS) Immune thrombocytopenic purpura (ITP) Guillain-Barré syndrome (GBS) Myocarditis Pericarditis Myopericarditis Chest pain Deep venous thrombosis Pulmonary embolism Bell’s palsy In 2021 1,125 appointments made at the adult vaccine safety clinic at Sir Charles Gairdner Hospital, up from seven in 2020. 439 appointments made at the Perth Children’s Hospital specialist immunisation clinic, up from 214 in 2020.

Professor Robert Clancy talks us through his newly developed oral preventive treatment, protecting against serious illness and death from respiratory infections.

New WHO International Health Regulations concerns Mr Andrew Bridgen addresses European Parliament https://www.youtube.com/watch?v=wADMuGoLgjA Petition https://petition.parliament.uk/petitions/635904 Article-by-Article Compilation of Proposed Amendments https://apps.who.int/gb/wgihr/pdf_files/wgihr1/WGIHR_Compilation-en.pdf WHOs ‘prospective’ on IHRs https://www.who.int/news-room/questions-and-answers/item/international-health-regulations-amendments

Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine https://onlinelibrary.wiley.com/doi/10.1111/eci.13998 Numbers of suspected adverse events (SAEs), after BNT612b2 mRNA vaccination in Denmark. 27 December 2020–11 January 2022, (population 5.8 million) (According to the number of doses per vaccine batch) Each dot represents a single vaccine batch. By 11 November 2022 (European area) 701 million doses of Pfizer given 971,021 reports of suspected adverse effects (SAEs) Clinical data on individual vaccine batch levels have not been reported (batch-dependent variation in the clinical efficacy and safety of authorized vaccines would appear to be highly unlikely) We therefore examined rates of SAEs between different BNT162b2 vaccine batches administered in Denmark Data on all SAE cases, Danish Medical Agency (DKMA) SAE seriousness was classified as non-serious, serious (hospitalization or prolongation of existing hospitalization, life-threatening illness, permanent disability or congenital malformation) or SAE-related d**** respectively. Anonymized data 4,026,575 persons 52 different BNT162b2 vaccine batches (2,340–814,320 doses per batch) 43,496 SAEs were registered in 13,635 persons 61,847 batch-identifiable SAEs, of which 14,509 (23.5%) were classified as severe, 579 (0.9%) were SAE-related deaths

Nearly 100,000 more deaths involving heart conditions and stroke than usual since pandemic began https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2023/june/100000-excess-deaths-cardiovascular-disease https://www.youtube.com/watch?v=819x0hs2yL8 Official excess deaths data https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9 Since the pandemic began On average, over 500 additional deaths a week from cardiovascular disease Included cardiovascular and cerebrovascular deaths More excess deaths involving cardiovascular conditions than any other disease groups A total of 96,540 extra cardiovascular deaths since February 2020 In the first year of the pandemic Covid-19 infection drove high numbers of excess deaths, Covid-19 have since fallen year-on-year, the number of deaths involving cardiovascular disease have remained high above expected levels. We believe that there are now other major factors likely driving the continued increase in excess deaths. We're calling on the UK Government to take charge of the increasingly urgent cardiovascular disease crisis. Dr Charmaine Griffiths, BHF Chief Executive It is deeply troubling that so many more people with cardiovascular disease have lost their lives over the last three years. For years now, it has been clear that we are firmly in the grip of a heart and stroke care emergency. There is no time to waste – Government must take control of this crisis to give heart patients and their loved ones hope of a better and healthier future. Latest figures People waiting for time-sensitive cardiac care, 390,000 Average ambulance response times for heart attacks and strokes, above 30 minutes since the beginning of 2022 (December 2022 they breached 90 minutes) Lack of primary health care Concerns of a potential rise in heart problems linked to Covid-19 People with and without pre-existing heart conditions, who caught Covid-19 before the vaccine roll-out, (i.e., in 2020) 40 % per cent more likely to develop cardiovascular disease, five times more likely to die in the 18 months after infection. BHF wants Prioritisation of NHS heart care Renewed focus on preventing the causes of cardiovascular disease Supercharging cardiovascular research for new treatments and cures Dr Sonya Babu-Narayan, (Associate Medical Director) Covid-19 no longer fully explains the significant numbers of excess deaths involving cardiovascular disease. Then focuses on treatment difficulties Iatrogenesis https://www.merriam-webster.com/dictionary/iatrogenic Induced unintentionally by a physician or surgeon or by medical treatment or diagnostic procedures Not mentioned

Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine https://onlinelibrary.wiley.com/doi/10.1111/eci.13998 71% of the suspected adverse reactions occurred in 4.2% of the vaccine batches Numbers of suspected adverse events (SAEs), after BNT612b2 mRNA vaccination in Denmark. 27 December 2020–11 January 2022, (population 5.8 million) (According to the number of doses per vaccine batch) Each dot represents a single vaccine batch. By 11 November 2022 (European area) 701 million doses of Pfizer given 971,021 reports of suspected adverse effects (SAEs) Clinical data on individual vaccine batch levels have not been reported (batch-dependent variation in the clinical efficacy and safety of authorized vaccines would appear to be highly unlikely) We therefore examined rates of SAEs between different BNT162b2 vaccine batches administered in Denmark Data on all SAE cases, Danish Medical Agency (DKMA) SAE seriousness was classified as non-serious, serious (hospitalization or prolongation of existing hospitalization, life-threatening illness, permanent disability or congenital malformation) or SAE-related d**** Anonymized data SAEs were counted on a batch level by linking individual SAEs to the batch label(s) of BNT162b dose(s) 10,793,766 doses administered 4,026,575 persons 52 different BNT162b2 vaccine batches (2,340–814,320 doses per batch) 43,496 SAEs were registered in 13,635 persons 61,847 batch-identifiable SAEs, of which 14,509 (23.5%) were classified as severe, 579 (0.9%) were SAE-related d***** Unexpectedly Rates of SAEs per 1000 doses varied considerably between vaccine batches From 1 SAE per 20 doses given to I in many thousands to zero Variabilities Vaccine manufacturing Storage Transportation Clinical handling and control Administration technique

Many thanks to Dr. Nyjon Eccles for giving us such valuable insights into a natural approach to health. Also this video looks at breast health and prevention of bresat cancer. For more on the work of Dr. Eccles, check out The Natural Doctor on https://thenaturaldoctor.org/

Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic A Systematic Review and Meta-Analysis 30th June 2023 Toronto https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2806712?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=063023 Key Points Analysis of 42 studies N = 102,984 youths (<19 years) Incidence of type 1 diabetes was higher during the COVID-19 pandemic compared with before the pandemic. The findings suggest the need to elucidate possible underlying mechanisms to explain temporal changes Synthesize estimates of changes in incidence rates Minimum observation period of 12 months during and 12 months before the pandemic (Also looked at incidence of DKA in new-onset diabetes during the pandemic.) Results, Type 1 diabetes incidence rates N = 38,149 youths First year of the pandemic, incidence rate ratio = 1.14 During months 13 to 24, incidence rate ratio = 1.27 (Expected 3% to 4% annual increase trends in Europe) Results, Type 2 diabetes incidence rates Ten studies reported incident in both periods. Eight studies, an increase incident of type 2 diabetes Results, DKA incidence rates Fifteen studies Incidence rate ratio = 1.26 Conclusions Future studies are needed to assess whether this trend persists, and may help elucidate possible underlying mechanisms to explain temporal changes. More from the study Some studies reported an association between SARS-CoV-2 infection and new-onset diabetes. However, (challenges in SARS-CoV-2 diagnosis), concerns about the validity of these studies. Data sets used in other studies did not capture asymptomatic SARS-CoV-2 There is no clear mechanism by which COVID-19 could directly or indirectly lead to new-onset type 1 or 2 diabetes. Purported direct mechanisms SARS-CoV-2 entry receptor ACE2 is expressed on insulin-producing β cells There is no clear underlying mechanism explaining the association between SARS-CoV-2 infection and subsequent increased risk of diabetes. Population-based studies suggest…. that the increase in incidence may be due to an immune-mediated mechanism. Proposed indirect effects of the COVID-19 pandemic and containment measures that may be associated with diabetes (contrary to what would be expected based on the decrease in viral infections among children) ‘Catch-up’ could only influence the first year of the pandemic Reflection on yesterday’s lab leak video and biological war As someone who has spent a number of years studying biological warfare (BW) and ways to defend against it, I'm not convinced that the Wuhan virus was not meant to be a BW agent. High lethality isn't necessarily required to be an effective weapon; it just needs to be able to incapacitate a significant number of people. The incapacitated people are no longer able to do their jobs, and the added benefit to the employer of the weapon is that those incapacitated people now take up more resources and more people to treat them than if they died. Also, the genetic techniques that they used, techniques that made it difficult to identify any man-made changes, is in line with one of the main attractions of BW - plausible deniability.

National Intelligence Officer for Weapons of Mass Destruction and Proliferation https://www.dni.gov/files/ODNI/documents/assessments/Report-on-Potential-Links-Between-the-Wuhan-Institute-of-Virology-and-the-Origins-of-COVID-19-20230623.pdf My impressions Many potential incriminating details from WIV are given Report then systematically tries to downplay the evidence IC genuinely does not know a lot of specifics Background Late March, US Congress, unanimously passed a law Everything US intelligence held on coronavirus origins must be made public. Public Law https://www.congress.gov/bill/118th-congress/senate-bill/619/text Not mentioned Only one focus of outbreak No animal intermediate identified Poor WHO visits WIV may have begun developing two Covid vaccines in November 2019 https://www.documentcloud.org/documents/23780776-mwg-fdr-document-04-16-23 (Prior to 8th December 2018) U.S. Consulate General in Wuhan An increase in adult Influenza-Like-Illness (ILI) October to November 2019 (accompanied by negative results) statistically significantly higher than reported in the previous 5 years “By mid-October 2019, the dedicated team at the U.S. Consulate General in Wuhan knew that the city had been struck by what was thought to be an unusually vicious flu season. The disease worsened in November.” China CDC None of the samples taken from the 18 animal species found in the market were positive for SARS- CoV-2. EcoHealth Alliance and NIH funding EcoHealth Alliance with the WIV, Project DEFUSE: Defusing the Threat of Bat-borne Coronaviruses Mid-October to mid-November 2019 WIV collected 20,000 bat and animal samples by 2019, but did not disclose all of the viruses Before 2019, the WIV published sequences in a public database, taken offline in September 2019